Skip to main content
Premium Trial:

Request an Annual Quote

Lexogen SLAM-seq Kits

Lexogen has launched its SLAM-seq line of products for metabolic RNA sequencing. The kits are based on technology developed at the Institute of Molecular Biotechnology in Vienna, Austria, that involves labeling metabolic RNA. The technology, thiol-linked alkylation for the metabolic sequencing of RNA, was described this week in a study published in Nature Methods. The SLAM-seq kit can be combined with Lexogen's QuantSeq 3' mRNA kit for library prep.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.